1. Home
  2. BNTX

as of 12-02-2025 3:41pm EST

$96.21
$2.09
-2.13%
Stocks Health Care Biotechnology: Biological Products (No Diagnostic Substances) Nasdaq

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Chart Type:
Time Range:
Founded: 2008 Country:
Germany
Germany
Employees: N/A City: N/A
Market Cap: 24.8B IPO Year: 2019
Target Price: $137.40 AVG Volume (30 days): 1.1M
Analyst Decision: Buy Number of Analysts: 11
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.80 EPS Growth: N/A
52 Week Low/High: $81.20 - $129.27 Next Earning Date: 11-03-2025
Revenue: $3,698,814,972 Revenue Growth: 3.70%
Revenue Growth (this year): -17.67% Revenue Growth (next year): 9.49%

AI-Powered BNTX Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 67.92%
67.92%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest BioNTech SE News

BNTX Breaking Stock News: Dive into BNTX Ticker-Specific Updates for Smart Investing

All BNTX News

Share on Social Networks: